ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 197

Improving Clinical Decisions for Gout Management: Effect of Online Case-Based Education

Nimish Mehta, Piyali Chatterjee-Shin and Karen Badal, Medscape, LLC, New York, NY

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Education, gout, hyperuricemia and outcomes, medical

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Education Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Gout is a chronic condition with a considerable effect on patient health and quality of life. Despite the availability of multiple pharmacologic treatments and evidence-based management guidelines, treatment targets are often not achieved in patients with gout. A study was conducted to determine if online, case-based intervention could improve clinical decisions made by rheumatologists and PCPs regarding the management of patients with gout.

Methods: Educational design included 2 online, interactive, patient cases presented using a “test, then teach” approach to elicit cognitive dissonance, with evidence-based feedback provided following each learner response. Educational effectiveness was assessed with a repeated-pairs pre-/post-assessment study design with 3 case-based questions and 1 confidence question, in which each individual served as his/her own control. McNemar’s chi-squared test assessed differences from pre- to post-assessment. P values <.05 are statistically significant. Cramer’s V was used to calculate the effect size (<0.05 no effect; 0.06-0.15 noticeable effect; 0.16-0.26 considerable effect; >0.26 extensive effect). The activity launched 12/26/2017, with data collected through 1/18/2018.

Results:

The analysis set consisted of responses from rheumatologists (n=73) and primary care physicians (PCPs, n=1053) who answered all assessment questions during the study period. Analysis of pre- vs post-intervention responses by demonstrated a significant improvement in overall competence of with considerable educational impact (rheumatologists: V = .276, P<.0001. PCPs: V = .358, P<.0001).

Average correct responses increase from 68% pre to 90% post education for rheumatologists, and 41% pre to 76% post for PCPs. Specific areas of improvement in clinical decisions include:

  • Addition of allopurinol to colchicine in a patient with serum urate level of 9.2 mg/d
  • Treatment with fixed-dose lesinurad/allopurinol combination therapy in a patient with adherence issues while maintaining target urate levels
  • Switching from allopurinol to febuxostat in a patient with uncontrolled serum urate levels and hypersensitivity to allopurinol based on HLA-B*5801 positivity

Post-education, 18% of rheumatologists and 36% of PCPs were more confident in using a treat-to-target approach when prescribing urate-lowering therapy in gout.

Conclusion:

This study demonstrated the success of online, interactive, case-based education on improving the evidence-based clinical decisions and confidence of rheumatologists and PCPs in selecting appropriate treatment for patients with gout using a treat-to-target approach.


Disclosure: N. Mehta, None; P. Chatterjee-Shin, None; K. Badal, None.

To cite this abstract in AMA style:

Mehta N, Chatterjee-Shin P, Badal K. Improving Clinical Decisions for Gout Management: Effect of Online Case-Based Education [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/improving-clinical-decisions-for-gout-management-effect-of-online-case-based-education/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-clinical-decisions-for-gout-management-effect-of-online-case-based-education/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology